Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (CH:ZBH)
:ZBH
Earnings Data
Report Date
Feb 05, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.94Last Year’s EPS
1.87Same Quarter Last Year
Moderate Buy
Based on 21 Analysts Ratings
Earnings Call Summary
Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant growth in the U.S. and technological advancements, but also highlighted challenges in emerging markets and specific segments, leading to a cautious adjustment in revenue guidance.Company Guidance
U.S. Business Growth
Zimmer Biomet's U.S. business grew 5.6% on an organic constant currency basis, marking the best performance in over two years, driven by new product adoption and strong robotic placements.
Knees and Hips Segment Performance
The U.S. Knees segment grew 3.5%, driven by Persona OsseoTi and Oxford knee implants, while the U.S. Hips grew 4% due to products like Z1, HAMMR, and OrthoGrid.
Technology and Data Segment Growth
The Technology and Data, Bone Cement, and Surgical segment saw an 11.3% increase globally, fueled by strong ROSA placements.
Adjusted Earnings Per Share Growth
Zimmer Biomet reported adjusted earnings per share of $1.90, a 9.2% increase year-over-year, despite challenges such as tariffs and integration costs.
Iodine Technology Launch in Japan
Zimmer Biomet received PMDA approval for iodine-treated hip implants in Japan, a first-of-its-kind technology that addresses periprosthetic joint infections.
CH:ZBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CH:ZBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | CHF81.50 | CHF81.50 | 0.00% |
Aug 07, 2025 | CHF71.81 | CHF71.81 | 0.00% |
May 05, 2025 | CHF108.52 | CHF108.52 | 0.00% |
Feb 06, 2025 | CHF108.31 | CHF108.31 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Zimmer Biomet Holdings (CH:ZBH) report earnings?
Zimmer Biomet Holdings (CH:ZBH) is schdueled to report earning on Feb 05, 2026, Before Open (Confirmed).
What is Zimmer Biomet Holdings (CH:ZBH) earnings time?
Zimmer Biomet Holdings (CH:ZBH) earnings time is at Feb 05, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Zimmer Biomet Holdings stock?
The P/E ratio of Zimmer Biomet Holdings is N/A.
What is CH:ZBH EPS forecast?
CH:ZBH EPS forecast for the fiscal quarter 2025 (Q4) is 1.94.